Investors / Asahi Kasei Ventures
Asahi Kasei Ventures
Corporate VC
Asahi Kasei Ventures is a corporate venture arm of Asahi Kasei that invests in companies across materials, homes, and healthcare. Its portfolio spans areas such as energy and materials, industrial IoT and AI, digital health, medical devices, pharmaceuticals, and construction.
Invests inHealthcare & BiotechIndustrial & Manufacturing
In its own wordsmaterialshealthcareindustrial iotdigital healthenergyconstruction
Your fit with Asahi Kasei Ventures
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsAsahi Kasei Ventures lists 48 checked portfolio companies on its own site and is named in 3 funding rounds. Its most frequent entry is Series A, 33% of the companies with a known first round. Its largest themes are Healthcare & Biotech (33%), Industrial & Manufacturing (29%) and Real Estate & Construction (6%). 71% of its companies are based in United States. It invests most often alongside Creative Destruction Lab, ShangBay Capital and ATEL Ventures.
Counts come from funding rounds that name Asahi Kasei Ventures, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Asahi Kasei Ventures' whole history. Rounds on record name 3 companies; its own site lists 48. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundAsahi Kasei Ventures does not state its stages on its site, so only what it does is shown.
Show as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 33% |
| Series B | 33% |
| Growth | 33% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 1 | 0 |
| '26 | 2 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 82th | 48 companies |
| Recent activity | 69th | 2 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 61th | 4% of companies confirmed by a round |
| Sector focus | 62th | 33% in its largest sector |
| Reach | 70th | 4 countries |
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 33% | 15% |
| Industrial & Manufacturing | 29% | 7% |
| Real Estate & Construction | 6% | 3% |
| AI & Machine Learning | 6% | 18% |
| Consumer | 6% | 3% |
| E-commerce & Marketplaces | 5% | 6% |
| Education | 5% | 7% |
| Fintech | 3% | 12% |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Creative Destruction Lab | 4 |
| ShangBay Capital | 3 |
| ATEL Ventures | 2 |
| Collaborative Fund | 2 |
| Finindus | 2 |
| JIC Venture Growth Investments | 2 |
| Mission BioCapital | 2 |
| NEA | 2 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers4696%
- No longer answers00%
- Points to another company24%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Creative Destruction Lab
Compare Asahi Kasei Ventures head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Asahi Kasei Ventures| Date | Company | Stage |
|---|---|---|
| 19 Mar 2026 | Series A | |
| 7 Jan 2026 | Series B | |
| 16 Apr 2025 | Series C+ |
Round details for Asahi Kasei Ventures
Amounts, full round histories and every co-investor in Asahi Kasei Ventures' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
48 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| AM Batteries manufactures lithium-ion battery electrodes using a dry coating process | Industrial & ManufacturingClimate & Energy | Portfolio page | ||
| Avation Medical develops and offers a wearable at-home treatment for overactive bladder | Healthcare & Biotech | Portfolio page | ||
| Axine destroys persistent contaminants in industrial wastewater using electrochemical oxidation technology | Industrial & ManufacturingEnterprise Software | Portfolio page | ||
| Azafaros develops treatments for rare neurological diseases, including lysosomal storage disorders. | Healthcare & Biotech | Portfolio page | ||
| The company provides supply chain traceability software for faster compliance | Industrial & ManufacturingConsumer | Portfolio page | ||
| The company produces high-performance single-crystal aluminum nitride substrates for optoelectronic, RF and power applications. | Industrial & ManufacturingAI & Machine Learning | Portfolio page | ||
| The company provides contract manufacturing and quality control testing for gene and cell therapies | Healthcare & Biotech | Portfolio page | ||
| Everactive creates self-powered chips for wireless Ambient IoT devices that can sense, process, and wirelessly transmit data continuously using energy harvested from the environment. | Industrial & ManufacturingConsumer | Portfolio page | ||
| Exactmer develops and manufactures technologies for oligonucleotide therapeutics and advanced polymer therapeutic manufacturing | Healthcare & Biotech | Portfolio page | ||
| Koya helps marketplaces and procurement platforms with catalog data management. | E-commerce & Marketplaces | Portfolio page | ||
| Glycomine is developing replacement therapies for rare genetic diseases | Healthcare & Biotech | Apr 2025Series C+ | Page + round | |
Healthcare & Biotech | Portfolio page | |||
| Hazel Technologies develops and provides innovative solutions to extend the quality of fruits and vegetables, reduce waste and increase profitability in the produce supply chain. | AI & Machine LearningAI & Machine Learning | Portfolio page | ||
| HistoWiz provides automated histopathology services for researchers, including tissue specimen processing and analysis | Healthcare & Biotech | Portfolio page | ||
| IGS develops and commercializes technology to visualize the invisible, such as microwave mammography and non-destructive inspection systems | Healthcare & BiotechIndustrial & Manufacturing | Portfolio page | ||
| Impulse designs and sells high-performance cooktops and related products | Consumer | Portfolio page | ||
| Ionomr Innovations Inc. develops advanced ion-exchange membranes and polymers for various applications, including hydrogen production and fuel cells. | Industrial & ManufacturingEducation | Portfolio page | ||
| KEWAZO develops robotics and AI for industrial maintenance and construction | Industrial & Manufacturing | Mar 2026Series A | Page + round | |
| Kins provides physical therapy services, including at-home and virtual sessions, for various health conditions, including women's and men's pelvic health and chronic illnesses. | Healthcare & Biotech | Portfolio page | ||
| LUCA Science is a pre-clinical stage biotechnology company focused on developing functional mitochondria as therapeutic agents | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- asahikaseiventures.com
- Last read
- 5 Nov 2026
- Watching since
- 6 Nov 2026
- Rounds since
- 16 Apr 2025
- Companies checked
- 48
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Asahi Kasei Ventures' profile as data
Pull Asahi Kasei Ventures' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/asahikaseiventures.com
# also
GET /v1/firms/asahikaseiventures.com/portfolio
GET /v1/firms/asahikaseiventures.com/coinvestors
GET /v1/firms/asahikaseiventures.com/news